Crohn’s Disease Not Exempt From Racial DisparitiesCrohn’s Disease Not Exempt From Racial Disparities https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Gina Bericchia Gina Bericchia https://pediatricsnationwide.org/wp-content/uploads/2021/03/Gina-Bericchia-2-1.jpg
- May 07, 2015
- Gina Bericchia
Disparities exist among pediatric Crohn’s patients of different races for a number of health care metrics.
A study published in the journal Inflammatory Bowel Diseases found significant differences in hospital readmissions, medication usage and both medical and surgical complications of children with Crohn’s disease related to race. In the study, black children had a 1.5 times higher frequency of hospital readmissions because of Crohn’s disease compared to white children.
“We found racial inequalities exist among children and adolescents with Crohn’s disease, likely due to a combination of genetic and environmental differences,” says Jennifer Dotson, MD, MPH, gastroenterologist in the IBD Center at Nationwide Children’s Hospital and principal investigator in the Center for Innovation and Pediatric Practice. “This is one of the first studies to investigate the rate of various health disparities in the Crohn’s disease population in pediatrics, despite the fact that 25 percent of the time, Crohn’s disease is diagnosed in childhood.”
Using data from the Pediatric Health Information System database, a large, regionally diverse system, the researchers examined racial disparities in the treatment and outcomes of hospitalized white and black pediatric patients with moderate to severe Crohn’s disease. The study evaluated more than 4,000 patients up to age 21 who were admitted to a hospital due to their disease between 2004 and 2012. Black children had a shorter time to first readmission.
“A physician or other clinical staff may not readily identify these racial differences at a single-practice level, but these gaps may be important on a larger scale,” explains Dr. Dotson. “Further studies need to help identify the causes of these racial differences so we can design interventions for hospitals and physician offices that can reduce population level disparities. Clinicians at Nationwide Children’s involved in the study are keeping this in mind and continuing to collect data.”
They are now examining some of the outpatient factors that may result in disparities, such as frequency of follow-up, and further investigating racial and socioeconomic disparities in treatment and outcomes of children with Crohn’s disease.
The researchers also found black children were more likely to have anemia, vitamin D deficiency, endoscopic procedures, blood product transfusions and treatment with steroids and biologic agents compared to white children with Crohn’s disease. However, race did not influence the risk of bowel surgery, a common procedure for children with Crohn’s disease.
Why the Difference?
“Some of the differences in our study are likely attributable to intrinsic differences in disease between blacks and whites,” says Dr. Dotson, who is also a faculty member at The Ohio State University Wexner Medical Center. “For example, more procedures are likely a result of the increased rate of perianal disease in blacks. Other differences may reflect disparities in care, although biologic differences can’t be excluded.”
According to Dr. Dotson, the increased usage of corticosteroids and biologic medications among black children in the study could suggest a more severe disease course that may be attributable to worse intrinsic disease in black children. But it is equally possible that black patients were more ill at the time of hospital admissions due to delays in seeking care or impaired access to care, and thus required more intensive therapy, she says. The researchers also found black children had a lower median income and were more likely to have Medicaid.
“Black children were slightly older at the first admission than white children, which could represent a subtle marker of diminished access to medical care or a delay in disease recognition,” says Dr. Dotson, who explained other studies have shown that the role of biology in health disparities in chronic diseases is often modest, and there are many other factors, such as access to care and health literacy, that contribute to disparities in care.
Significant racial, ethnic and socioeconomic disparities in access to health care and quality of care have been found throughout the United States in other conditions, including the treatment of ovarian cancer, asthma and ADHD, with little improvement in disparities being reported in the past decade. Disparities have been shown to contribute to suboptimal health care outcomes for minorities and low-income groups, as well as inefficiencies in health care delivery systems.
“Financial barriers to outpatient care and self-management, such as transportation, medication and nutrition needs, may have impacted the outcome for these children,” Dr. Dotson says.
Dr. Dotson and her collaborators on the study stress that further primary research in understanding health system barriers and disparities, and standardization of care is needed to ultimately improve health care delivery and minimize health care disparities to improve the health and quality of life of children with Crohn’s disease and other chronic conditions.
Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV. Racial disparities in readmission, complications, and procedures in children with Crohn’s disease. Inflammatory Bowel Diseases. 2015 Apr, 21(4):801-8.
About the author
- Posted In:
- In Brief
You might also like
Enhancing Intestinal Rehabilitation Workflow with Disease-Specific Documentation ToolsEnhancing Intestinal Rehabilitation Workflow with Disease-Specific Documentation Tools https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Erin Gregory Erin Gregory https://secure.gravatar.com/avatar/?s=96&d=mm&r=g
Tissue Engineered Trachea: State of the ResearchTissue Engineered Trachea: State of the Research https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Lauren Dembeck Lauren Dembeck https://pediatricsnationwide.org/wp-content/uploads/2021/03/Dembeck_headshot.gif
Oncolytic Virus Immunotherapy Safe and Tolerable in Children With Relapsed or Refractory Solid TumorsOncolytic Virus Immunotherapy Safe and Tolerable in Children With Relapsed or Refractory Solid Tumors https://pediatricsnationwide.org/wp-content/uploads/2020/06/AdobeStock_57532575-1024x683.jpg 1024 683 Lauren Dembeck Lauren Dembeck https://pediatricsnationwide.org/wp-content/uploads/2021/03/Dembeck_headshot.gif